+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019

  • ID: 4772321
  • Report
  • 168 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aerophase Inc
  • AstraZeneca Plc
  • Globe Medical Tech Inc
  • Lupin Pharmaceuticals Inc
  • Min USA LLC
  • Pearl Therapeutics Inc
  • MORE
Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Metered Dose Inhaler Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Metered Dose Inhaler Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Metered Dose Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aerophase Inc
  • AstraZeneca Plc
  • Globe Medical Tech Inc
  • Lupin Pharmaceuticals Inc
  • Min USA LLC
  • Pearl Therapeutics Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Metered Dose Inhaler Devices Overview

3 Products under Development
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials

4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development

5 Metered Dose Inhaler Devices Companies and Product Overview
5.1 Adamis Pharmaceuticals Corp Company Overview
5.2 Aerophase Inc Company Overview
5.3 AstraZeneca Plc Company Overview
5.4 Circassia Pharmaceuticals Plc Company Overview
5.5 Globe Medical Tech Inc (Inactive) Company Overview
5.6 Lab Automate Technologies Inc Company Overview
5.7 Lupin Pharmaceuticals Inc Company Overview
5.8 Medicom Innovation Partner a/s Company Overview
5.9 Min USA LLC Company Overview
5.10 Pearl Therapeutics Inc Company Overview
5.11 Reciprocal Labs Corp Company Overview
5.12 Rensselaer Polytechnic Institute Company Overview
5.13 Vectura Group Plc Company Overview
5.14 Verona Pharma Plc Company Overview

6 Metered Dose Inhaler Devices- Recent Developments
6.1 Apr 30, 2019: Merck announces first-quarter 2019 financial results
6.2 Apr 24, 2019: Novartis starts 2019 with strong sales and double digit core operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
6.3 Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
6.4 Apr 12, 2019: Cipla launches Niveoli, India’s first extra-fine ICS-LABA combination HFA inhaler
6.5 Apr 09, 2019: Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off
6.6 Apr 02, 2019: Alcon announces Timothy Stonesifer as Chief Financial Officer
6.7 Apr 02, 2019: 3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility
6.8 Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors
6.9 Mar 26, 2019: Vectura Group 2018 preliminary results
6.10 Mar 22, 2019: Sosei Heptares announces that Ultibro Breezhaler and Seebri Breezhaler launched in China for the treatment of COPD

7 Appendix
7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

List of Tables
  • Table 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Table 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
  • Table 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  • Table 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  • Table 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials
  • Table 6: Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
  • Table 7: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Table 8: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Beclomethasone MDI - Product Status
  • Table 10: Beclomethasone MDI - Product Description
  • Table 11: Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Metered Dose Inhaler - Product Status
  • Table 13: Metered Dose Inhaler - Product Description
  • Table 14: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Bevespi Aerosphere Inhalation Aerosol - Product Status
  • Table 16: Bevespi Aerosphere Inhalation Aerosol - Product Description
  • Table 17: AstraZeneca Plc - Ongoing Clinical Trials Overview
  • Table 18: Bevespi Aerosphere Inhalation Aerosol - A Phase I, Single-dose, Gamma Scintigraphy Study to Assess the Pulmonary Deposition of Technetium-99m Radiolabelled Budesonide, Glycopyrronium and Formoterol Fumarate MDI in Patients with Moderate to Severe/Very Severe COPD
  • Table 19: Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Fliveo - Product Status
  • Table 21: Fliveo - Product Description
  • Table 22: Fluticasone propionate/Salmeterol xinafoate pMDI - Product Status
  • Table 23: Fluticasone propionate/Salmeterol xinafoate pMDI - Product Description
  • Table 24: Circassia Pharmaceuticals Plc - Ongoing Clinical Trials Overview
  • Table 25: Fluticasone propionate/Salmeterol xinafoate pMDI - A Phase III Registration Study of Seretide Substitute (PSX2005)
  • Table 26: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Inhaler - Product Status
  • Table 28: Inhaler - Product Description
  • Table 29: Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Ultrasonic Metered Dose Inhaler - Product Status
  • Table 31: Ultrasonic Metered Dose Inhaler - Product Description
  • Table 32: Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Albuterol MDI - Product Status
  • Table 34: Albuterol MDI - Product Description
  • Table 35: Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Asmair - Product Status
  • Table 37: Asmair - Product Description
  • Table 38: Min USA LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Envi - Product Status
  • Table 40: Envi - Product Description
  • Table 41: Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: PT001 - Product Status
  • Table 43: PT001 - Product Description
  • Table 44: PT010 - Product Status
  • Table 45: PT010 - Product Description
  • Table 46: Pearl Therapeutics Inc - Ongoing Clinical Trials Overview
  • Table 47: PT010 - A Randomized, Double-blind, Multi-center, Parallel-group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects with Moderate to Very Severe COPD (Ethos)
  • Table 48: Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Connected Metered Dose Inhaler - Product Status
  • Table 50: Connected Metered Dose Inhaler - Product Description
  • Table 51: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Bloom Inhaler - Product Status
  • Table 53: Bloom Inhaler - Product Description
  • Table 54: Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Flutiform pMDI - Product Status
  • Table 56: Flutiform pMDI - Product Description
  • Table 57: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: RPL554 - Metered Dose Inhaler - Product Status
  • Table 59: RPL554 - Metered Dose Inhaler - Product Description
  • Table 60: Glossary
List of Figures
  • Figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  • Figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
  • Figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  • Figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Adamis Pharmaceuticals Corp
  • Aerophase Inc
  • AstraZeneca Plc
  • Circassia Pharmaceuticals Plc
  • Globe Medical Tech Inc
  • Lab Automate Technologies Inc
  • Lupin Pharmaceuticals Inc
  • Medicom Innovation Partner a/s
  • Min USA LLC
  • Pearl Therapeutics Inc
  • Reciprocal Labs Corp
  • Rensselaer Polytechnic Institute
  • Vectura Group Plc
  • Verona Pharma Plc
Note: Product cover images may vary from those shown
Adroll
adroll